After completing this activity, participants should be better able to: Apply current diagnostic criteria to identify patients with IBS-C Evaluate pharmacological treatments for IBS-C based on their efficacy, safety, and approved indications Integrate current recommendations and evidence to guide individualized treatment plans for patients with IBS-C Implement strategies to improve access and collaboration in the management of IBS-C in rural and underserved communities
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
20 of 20 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedJun 15, 2026
-
Last day to claim creditDec 16, 2026 2 months left
-
Talem Health, LLC Bridging Gaps in Renal Cell Carcinoma Management: Strengthening Access and Outcomes in Community Practice
-
Talem Health, LLC Optimizing Treatment of mTNBC in the Community Oncology Setting: Treatment Selection, Sequencing Strategies, and Team-Based Toxicity Management
-
Talem Health, LLC Novel and Targeted Therapies for Relapsed/Refractory DLBCL and FL: Improving Access and Outcomes in the Community Setting
